BDX Updates PureWick Study as It Targets Lower Catheter Use
at www.tipranks.com (Fri, 13-Nov 11:31 AM)
BDX highlights cash-flow surge as fiscal 2027 adjusted EPS guidance moves to $13.10–$13.30
Market Chameleon (Thu, 5-Nov 7:54 AM)